Results

Total Results: 1,494 records

Showing results for "harms".

221. Single-arm studies in comparative effectiveness reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
     January 01, 2013 - Ten used single group studies to report only harms, 2 reported only nonharm effects, while the remaining … 9 reported both harms and nonharm effects. … While the value of using single group studies to identify and quantify the occurrence of harms a … only benefits, while the remaining 9 (43%) used single group studies for reporting both harms and … 0 (0) Quantitatively combined single group studies with comparative studies for harms 0 (0) Described

222. AHRQ Evidence-based Practice Center (EPC) Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-march-2023-grand-rounds-slides.pdf
     January 01, 2023 - by identifying characteristics of telehealth delivery, patient populations, settings, benefits and harms … What are the benefits and harms of telehealth during the COVID-19 era? 1. … Results KQ 2.What are the benefits and harms … 20 Results KQ 2.What are the benefits and harms … insufficient to support conclusions on other uses, outcomes or populations • No studies reported harms

223. Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
     January 15, 2015 - What are the adverse effects, consequences, or harms of testing? … What are the adverse effects, consequences or harms of testing? c. … What are the adverse effects, consequences or harms of testing? c. … What are the adverse effects, consequences or harms of testing? c. … Harms related to subsequent testing will be evaluated.

224. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
     June 01, 2022 - : 105 studies (2 new) 2b Harms in subgroups: 18 studies 2c Opioids vs. non-opioids harms: 14 studies … Harms and Adverse Events: a. … endocrinological harms, infections, cardiovascular events, cognitive harms, and psychological harms … harms, infections, cardiovascular events, cognitive harms, and mental health harms (e.g., depression … harms, infections, cardiovascular events, cognitive harms, and mental health harms (e.g., depression

225. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
     August 04, 2023 - What is the frequency and severity of harms associated with healthcare associated infections and asymptomatic … surveillance PSPs for MRSA, CRE, C.auris, and C.difficile have been used to prevent or mitigate the harms … surveillance PSPs for MRSA, CRE, C.auris, and C.difficile that have been used to prevent or mitigate the harms … Review Questions 1 and 2, without conducting a systematic search for all evidence on the targeted harms … surveillance PSPs for MRSA, CRE, C.auris, and C.difficile have been used to prevent or mitigate the harms

226. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-failure-rescue-protocol-amendment.pdf
     September 19, 2023 - What is the frequency and severity of harms associated with the failure to rescue that is targeted … What patient safety measures or indicators have been used to examine the harms associated with this … What rapid response system PSPs have been used to prevent or mitigate the harms and in what settings … What is the rationale for the PSPs that have been used to prevent or mitigate the harms associated … and related patient safety measures or indicators as these harms are well documented in this body

227. AHRQ Slide Template-Widescreen
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-child-adolesc-mental-health-grand-rounds.pptx
     May 22, 2025 - What are the comparative effects and harms of treatment interventions, used alone or in combination, … supporting evidence has been extrapolated from studies on adults 55 To assess the effectiveness and harms … To synthesize data on effect modifiers of effectiveness and harms when available. … high risk Small body of evidence, imprecise estimates with CI that includes appreciable benefits and harms … At this time, effectiveness and harms of these treatments are uncertain. 70 1 before after study on

228. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
     July 01, 2023 - What patient safety measures or indicators have been used to examine the harms associated with sepsis … What patient safety practices (PSPs) have been used to prevent or mitigate harms associated with sepsis … What is the rationale for PSPs used to prevent or mitigate harms associated with sepsis? 5. … best answer the questions without conducting a systematic search for all evidence on the targeted harms … We will 5 focus on the harms and patient safety measures or indicators that are addressed in the

229. AHRQ’s Evidence-based Practice Center Program Synthesizing evidence to improve health care practice and delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-synthesizing-evidence-improve.pdf
     July 01, 2020 - Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions ◆ Assessing Harms … Quantitative Synthesis Topics ◆ Handling Continuous Outcomes in Quantitative Synthesis ◆ Assessing Harms

230. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - Key Question 2: What are the harms and comparative harms of treatments for chronic urinary retention … modify the harms of treatment? … Given the relative infrequency of harms occurrence and the inconsistency in reporting harms across studies … Harms were inconsistently measured and reported Adequately collect and report data on harms. 2d … modify the harms of treatment?

231. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - What are the comparative harms associated with antiviral treatment? 3b! … Key Question 3: Do these harms differ according to patient subgroup characteristics? … No trial evaluated harms in patient sugbroups. •! … Do these harms differ according to patient subgroup characteristics? … No trial evaluated harms in patient sugbroups. •!

232. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - What are the comparative harms associated with antiviral treatment? 3b! … Key Question 3: Do these harms differ according to patient subgroup characteristics? … No trial evaluated harms in patient sugbroups. •! … Do these harms differ according to patient subgroup characteristics? … No trial evaluated harms in patient sugbroups. •!

233. Venous-Ulcers-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
     January 01, 2014 - For patients with chronic venous leg ulcers, what are the benefits and harms of using dressings that … For patients with chronic venous leg ulcers, what are the benefits and harms of surgical procedures … Benefits and Harms of Systemic Antibiotics Compared With Compression Systems, and Benefits and Harms … Benefits and Harms of Surgical Interventions Compared With Compression, and Benefits and Harms of Surgical … Studies also did not adequately address or describe potential harms in interventions.

234. Hepatitis-C Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
     November 01, 2012 - What are the comparative harms associated with antiviral treatments? b. … Do these harms differ according to patient subgroup characteristics, including HCV genotype, age, race … of antiviral therapies (including flulike Patients with chronic hepatitis C virus infection Harms … Low Key Question 3b Do these harms differ according to patient subgroup characteristics? … Dual Therapy With Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin Harms No trial evaluated harms

235. Migraine-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
     June 01, 2013 - Key Question 2: What are the comparative harms from pharmacologic treatments for preventing migraine … the adverse effects of drugs in children with migraine.20 We defined harms as the totality of all … We analyzed harms regardless of how authors perceived the causality of treatments. … Sixteen nonrandomized studies reported harms of migraine preventive drugs in children. … Few included trials examined the seriousness or bothersomeness of harms with drugs.

236. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - For key questions, the effectiveness were evaluated by each condition, and the harms were assessed … The harms may not be impacted by the underlying condition, or too sparse to evaluate by condition, … but it is helpful to state clearly why looking at harms across all conditions. … Many of the harms of antipsychotics are well know and influence prescribing practices. … We had been specific to how confounding is limited for many unanticipated harms in treatment naïve

237. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - For key questions, the effectiveness were evaluated by each condition, and the harms were assessed … The harms may not be impacted by the underlying condition, or too sparse to evaluate by condition, … but it is helpful to state clearly why looking at harms across all conditions. … Many of the harms of antipsychotics are well know and influence prescribing practices. … We had been specific to how confounding is limited for many unanticipated harms in treatment naïve

238. Multiple-Sclerosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
     April 01, 2015 - for either continuing or discontinuing, since that decision can be informed by the benefits or harms … What is the evidence for long-term harms? c. … • Broad variation in harms reporting precludes informative aggregation and summary. … Similarly, overall long-term harms were found to be no different from short-term harms. … The low-strength evidence showing long-term harms to be generally similar to short-term harms may

239. hemorrhage-postpartum-protocol-140611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
     June 11, 2014 - Harms may include fever, vomiting, vascular perforation, uterine ischemia, thrombosis, fertility loss … We also note that we will consider future pregnancy complications in our assessment of harms. … We will test the POPLINE database to determine whether it provides additional intervention or harms … We will use the McMaster Quality Assessment Scale of Harms (McHarm) tool to assess harms studies.52 … McMaster Quality Assessment Scale of Harms (McHarm) for primary studies.

240. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
     March 14, 2012 - It is important to consider potential harms of testing such as capsule retention, radiation exposure … ○ For the assessment of harms, we will include wireless motility capsule testing conducted in any … Utilization of other health care services such as hospitalizations and physician visits ○ Harms … • For the outcome of harms, we will not require a comparison group. …  For the outcome of harms, we will not require a comparison group.